Aug 07, 2015. /Lesprom Network/. Bio Pappel’s EBITDA reached $616 during the 2Q 2015, representing an increase of 25.3% when compared to the 2Q 2014, due to an increase of 10% in shipments, going from 315 thousand metric tons to 346 thousand metric tons; and higher net sales, which rose from $3,231 million to $4,071 million, representing a 26% annual increase, as the company said in the press release received by Lesprom Network.

Regarding the first half of the year, despite the tough business environment, Bio Pappel posted a $1,145 million EBITDA, up from $1,022 recorded during the same period of 2014, representing an increase of 12%, driven by 9% higher shipments that went from 620 thousand metric tons to 672 thousand metric tons and net sales increased 18% from $6,265 to $7,409.

The foregoing was reflected in an incremental EBITDA of $123 million. Bio Pappel’s financial proforma ratios of at the end of the 2Q including Scribe acquisition were: Leverage (Net Debt / EBITDA LTM) of 2.9 times; and interest coverage (EBITDA LTM / Interest LTM) of 3.6 times. During the 2Q 2015, the Company recorded a $204 million Capex, out of which $37 million were funded, in a long-term basis, by its suppliers.